Baker Chad R continued to hold its stake in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 61,105 shares of the conglomerate’s stock at the close of the 2nd quarter. Danaher Corporation comprises approximately 2.0% of Baker Chad R’s holdings, making the stock its 19th largest position. Baker Chad R’s holdings in Danaher Corporation were worth $5,157,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the stock. Optimum Investment Advisors lifted its position in shares of Danaher Corporation by 1.8% in the 2nd quarter. Optimum Investment Advisors now owns 14,134 shares of the conglomerate’s stock valued at $1,193,000 after acquiring an additional 250 shares in the last quarter. AHL Partners LLP lifted its position in shares of Danaher Corporation by 8.6% in the 2nd quarter. AHL Partners LLP now owns 99,135 shares of the conglomerate’s stock valued at $8,366,000 after acquiring an additional 7,817 shares in the last quarter. Boston Common Asset Management LLC purchased a new stake in shares of Danaher Corporation in the 2nd quarter valued at approximately $5,491,000. Sun Life Financial INC lifted its position in shares of Danaher Corporation by 15,792.9% in the 2nd quarter. Sun Life Financial INC now owns 4,450 shares of the conglomerate’s stock valued at $376,000 after acquiring an additional 4,422 shares in the last quarter. Finally, Institute for Wealth Management LLC. purchased a new stake in shares of Danaher Corporation in the 2nd quarter valued at approximately $494,000. Institutional investors and hedge funds own 75.49% of the company’s stock.
In other news, CFO Daniel L. Comas sold 88,184 shares of Danaher Corporation stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $91.02, for a total value of $8,026,507.68. Following the sale, the chief financial officer now directly owns 227,816 shares in the company, valued at $20,735,812.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the sale, the insider now owns 45,748 shares in the company, valued at $3,790,679.28. The disclosure for this sale can be found here. Insiders sold 153,639 shares of company stock worth $13,632,773 over the last quarter. 12.20% of the stock is owned by corporate insiders.
Several brokerages recently commented on DHR. Zacks Investment Research downgraded shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Royal Bank Of Canada restated a “hold” rating and issued a $88.00 price target on shares of Danaher Corporation in a research report on Wednesday, July 12th. Finally, Cowen and Company restated a “buy” rating and issued a $90.00 price target on shares of Danaher Corporation in a research report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Danaher Corporation presently has a consensus rating of “Buy” and an average price target of $93.31.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.com-unik.info/2017/10/30/baker-chad-r-continues-to-hold-stake-in-danaher-corporation-dhr.html.
Danaher Corporation (NYSE:DHR) opened at 92.25 on Monday. The stock’s 50 day moving average is $87.53 and its 200 day moving average is $84.48. Danaher Corporation has a 52 week low of $76.27 and a 52 week high of $92.26. The firm has a market cap of $64.09 billion, a price-to-earnings ratio of 29.44 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same period last year, the company earned $0.87 earnings per share. The firm’s revenue was up 9.6% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post $3.99 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were issued a $0.14 dividend. The ex-dividend date was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. Danaher Corporation’s dividend payout ratio (DPR) is presently 16.52%.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.